![](/img/cover-not-exists.png)
842 An open, single dose, anti-tumour effect study of 2-hydroxyflutamide as a controlled release product (Liproca® Depot) injected into the prostate in patients with localized prostate cancer
Tammela, T., Bjartell, A., Häggman, M.Volume:
15
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/s1569-9056(16)60844-8
Date:
March, 2016
File:
PDF, 109 KB
english, 2016